Oral manifestations in hiv disease

23,890 views 46 slides Jun 16, 2015
Slide 1
Slide 1 of 46
Slide 1
1
Slide 2
2
Slide 3
3
Slide 4
4
Slide 5
5
Slide 6
6
Slide 7
7
Slide 8
8
Slide 9
9
Slide 10
10
Slide 11
11
Slide 12
12
Slide 13
13
Slide 14
14
Slide 15
15
Slide 16
16
Slide 17
17
Slide 18
18
Slide 19
19
Slide 20
20
Slide 21
21
Slide 22
22
Slide 23
23
Slide 24
24
Slide 25
25
Slide 26
26
Slide 27
27
Slide 28
28
Slide 29
29
Slide 30
30
Slide 31
31
Slide 32
32
Slide 33
33
Slide 34
34
Slide 35
35
Slide 36
36
Slide 37
37
Slide 38
38
Slide 39
39
Slide 40
40
Slide 41
41
Slide 42
42
Slide 43
43
Slide 44
44
Slide 45
45
Slide 46
46

About This Presentation

ORAL MANIFESTATIONS OF HIV


Slide Content

Oral manifestations in hiv disease

Virus particle

Viral Replication Methods of transmission: Sexual transmission, presence of STD increases likelihood of transmission. Exposure to infected blood or blood products. Use of contaminated clotting factors by hemophiliacs. Sharing contaminated needles (IV drug users). Transplantation of infected tissues or organs. Mother to fetus, perinatal transmission variable, dependent on viral load and mother’s CD 4 count.

Transmission

Primary HIV Syndrome Mononucleosis-like, cold or flu-like symptoms may occur 6 to 12 weeks after infection. lymphadenopathy fever rash headache Fatigue diarrhea sore throat neurologic manifestations. no symptoms may be present

Primary HIV Syndrome Symptoms are relatively nonspecific. HIV antibody test often negative but becomes positive within 3 to 6 months, this process is known as seroconversion . Large amount of HIV in the peripheral blood. Primary HIV can be diagnosed using viral load titer assay or other tests. Primary HIV syndrome resolves itself and HIV infected person remains asymptomatic for a prolonged period of time, often years.

Clinical Latency Period HIV continues to reproduce, CD4 count gradually declines from its normal value of 500-1200. Once CD4 count drops below 500 , HIV infected person at risk for opportunistic infections. The following diseases are predictive of the progression to AIDS: persistent herpes-zoster infection (shingles) oral candidiasis (thrush) oral hairy leukoplakia Kaposi’s sarcoma (KS)

AIDS CD4 count drops below 200 person is considered to have advanced HIV disease If preventative medications not started the HIV infected person is now at risk for: Pneumocystis carinii pneumonia (PCP) cryptococcal meningitis toxoplasmosis If CD4 count drops below 50: Mycobacterium avium Cytomegalovirus infections lymphoma dementia Most deaths occur with CD4 counts below 50.

Other Opportunistic Infections Respiratory system Pneumocystis Carinii Pneumonia (PCP) Tuberculosis (TB) Kaposi's Sarcoma (KS) Gastro-intestinal system Cryptosporidiosis Candida Cytomegolavirus (CMV) Isosporiasis Kaposi's Sarcoma Central/peripheral Nervous system Cytomegolavirus Toxoplasmosis Cryptococcosis Non Hodgkin's lymphoma Varicella Zoster Herpes simplex Skin Herpes simple Kaposi's sarcoma Varicella Zoster

Oral manifestations of HIV

Saliva substitutes  – these include water, artificial salivas – mucin based , carboxymethylcellulose based Saliva stimulants  – organic acids – ascorbic acid and malic acid chewing gum parasympathomimetic  drugs ( choline esters, e.g. pilocarpine hydrochloride,cholinesterase inhibitors and other substances (sugar-free mints,  nicotinamide

candidiasis

2 Weeks with treatment

The condition often resolves rapidly with high dose acyclovir  but recurs once this therapy is stopped, or as the underlying immunocompromise worsens.   Topical  use of  podophyllum  resin or  retinoids  has also been reported to produce temporary remission.  Antiretroviral drugs  such as  zidovudine  may be effective in producing a significant regression of OHL.  Recurrence of the lesion may also signify that  highly active antiretroviral therapy  (HAART) is becoming ineffective

Vinblastine sulphate for treatment

Kaposi’s sarcoma (KS) Kaposi’s sarcoma (shown) is a rare cancer of the blood vessels that is associated with HIV. It manifests as bluish-red oval-shaped patches that may eventually become thickened. Lesions may appear singly or in clusters.

Topical 5 flurouracil

Topical corticosteroids Dexamethasone - 0.5mg/5ml for 1 min – 2- 3 times daily Predisone